TIL Therapy in Lung Cancer: Current Progress and Perspectives

Abstract Lung cancer remains the most prevalent malignant tumor worldwide and is the leading cause of cancer‐related mortality. Although immune checkpoint blockade has revolutionized the treatment of advanced lung cancer, many patients still do not respond well, often due to the lack of functional T...

Full description

Saved in:
Bibliographic Details
Main Authors: Weilei Hu, Yifei Bian, Hongbin Ji
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202409356
Tags: Add Tag
No Tags, Be the first to tag this record!